Cargando…

Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model

BACKGROUND: Buruli ulcer is a neglected tropical disease of the skin that is caused by infection with Mycobacterium ulcerans. We recently established an experimental pig (Sus scrofa) infection model for Buruli ulcer to investigate host-pathogen interactions, the efficacy of candidate vaccines and of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolz, Miriam, Ruggli, Nicolas, Borel, Nicole, Pluschke, Gerd, Ruf, Marie-Thérèse
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851394/ https://www.ncbi.nlm.nih.gov/pubmed/27128097 http://dx.doi.org/10.1371/journal.pntd.0004678

Ejemplares similares

Experimental Infection of the Pig with Mycobacterium ulcerans: A Novel Model for Studying the Pathogenesis of Buruli Ulcer Disease
por: Bolz, Miriam, et al.
Publicado: (2014)

Spatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis
por: Ruf, Marie-Thérèse, et al.
Publicado: (2016)

On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer
por: Doig, Kenneth D, et al.
Publicado: (2012)

Identification of the Mycobacterium ulcerans Protein MUL_3720 as a Promising Target for the Development of a Diagnostic Test for Buruli Ulcer
por: Dreyer, Anita, et al.
Publicado: (2015)

Mycobacterium ulcerans Persistence at a Village Water Source of Buruli Ulcer Patients
por: Bratschi, Martin W., et al.
Publicado: (2014)

Infiltrating leukocytes surround early Buruli ulcer lesions, but are unable to reach the mycolactone producing mycobacteria
por: Ruf, Marie-Thérèse, et al.
Publicado: (2017)

Targeting the Mycobacterium ulcerans cytochrome bc(1):aa(3) for the treatment of Buruli ulcer
por: Scherr, Nicole, et al.
Publicado: (2018)

Locally Confined Clonal Complexes of Mycobacterium ulcerans in Two Buruli Ulcer Endemic Regions of Cameroon
por: Bolz, Miriam, et al.
Publicado: (2015)

Mycobacterium ulcerans DNA in Bandicoot Excreta in Buruli Ulcer–Endemic Area, Northern Queensland, Australia
por: Röltgen, Katharina, et al.
Publicado: (2017)

Buruli ulcer: The Efficacy of Innate Immune Defense May Be a Key Determinant for the Outcome of Infection With Mycobacterium ulcerans
por: Röltgen, Katharina, et al.
Publicado: (2020)

Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer
por: Bolz, Miriam, et al.
Publicado: (2016)

Susceptibility to Mycobacterium ulcerans Disease (Buruli ulcer) Is Associated with IFNG and iNOS Gene Polymorphisms
por: Bibert, Stéphanie, et al.
Publicado: (2017)

Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice
por: Bieri, Raphael, et al.
Publicado: (2016)

Chronic wounds in Sierra Leone: Searching for Buruli ulcer, a NTD caused by Mycobacterium ulcerans, at Masanga Hospital
por: Please, Helen R., et al.
Publicado: (2021)

Single Nucleotide Polymorphism Typing of Mycobacterium ulcerans Reveals Focal Transmission of Buruli Ulcer in a Highly Endemic Region of Ghana
por: Röltgen, Katharina, et al.
Publicado: (2010)

Impact of Mycobacterium ulcerans Biofilm on Transmissibility to Ecological Niches and Buruli Ulcer Pathogenesis
por: Marsollier, Laurent, et al.
Publicado: (2007)

The Incubation Period of Buruli Ulcer (Mycobacterium ulcerans Infection)
por: Trubiano, Jason A., et al.
Publicado: (2013)

Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)
por: Yotsu, Rie R, et al.
Publicado: (2018)

Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans
por: Warryn, Louisa, et al.
Publicado: (2020)

Spontaneous Clearance of Mycobacterium ulcerans in a Case of Buruli Ulcer
por: Gordon, Claire L., et al.
Publicado: (2011)

Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease
por: Sarfo, Fred Stephen, et al.
Publicado: (2015)

Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease
por: Bolz, Miriam, et al.
Publicado: (2015)

Aquatic Insects and Mycobacterium ulcerans: An Association Relevant to Buruli Ulcer Control?
por: Silva, Manuel T, et al.
Publicado: (2007)

Risk of Buruli Ulcer and Detection of Mycobacterium ulcerans in Mosquitoes in Southeastern Australia
por: Lavender, Caroline J., et al.
Publicado: (2011)

Detection of Mycobacterium ulcerans in the Environment Predicts Prevalence of Buruli Ulcer in Benin
por: Williamson, Heather R., et al.
Publicado: (2012)

Linking the Mycobacterium ulcerans environment to Buruli ulcer disease: Progress and challenges
por: Dhungel, Laxmi, et al.
Publicado: (2021)

Buruli Ulcer (M. ulcerans Infection): New Insights, New Hope for Disease Control
por: Johnson, Paul D. R, et al.
Publicado: (2005)

Mycobacterium ulcerans Population Genomics To Inform on the Spread of Buruli Ulcer across Central Africa
por: Vandelannoote, Koen, et al.
Publicado: (2019)

Immunohistochemical Monitoring of Wound Healing in Antibiotic Treated Buruli Ulcer Patients
por: Andreoli, Arianna, et al.
Publicado: (2014)

Correction: Buruli Ulcer (M. ulcerans Infection): New Insights, New Hope for Disease Control
por: Johnson, Paul D. R, et al.
Publicado: (2005)

Mycobacterium ulcerans in Mosquitoes Captured during Outbreak of Buruli Ulcer, Southeastern Australia
por: Johnson, Paul D.R., et al.
Publicado: (2007)

A protocol for culturing environmental strains of the Buruli ulcer agent, Mycobacterium ulcerans
por: Zingue, Dezemon, et al.
Publicado: (2018)

Seasonal Pattern of Mycobacterium ulcerans, the Causative Agent of Buruli Ulcer, in the Environment in Ghana
por: Aboagye, Samuel Yaw, et al.
Publicado: (2017)

Understanding the transmission of Mycobacterium ulcerans: A step towards controlling Buruli ulcer
por: Muleta, Anthony J., et al.
Publicado: (2021)

Repurposing of statins for Buruli Ulcer treatment: antimicrobial activity against Mycobacterium ulcerans
por: Dominguez, Juan, et al.
Publicado: (2023)

Response to Treatment in a Prospective Cohort of Patients with Large Ulcerated Lesions Suspected to Be Buruli Ulcer (Mycobacterium ulcerans Disease)
por: Kibadi, Kapay, et al.
Publicado: (2010)

Geographic Distribution, Age Pattern and Sites of Lesions in a Cohort of Buruli Ulcer Patients from the Mapé Basin of Cameroon
por: Bratschi, Martin W., et al.
Publicado: (2013)

Primary cultivation: factors affecting contamination and Mycobacterium ulcerans growth after long turnover time of clinical specimens
por: Bratschi, Martin W, et al.
Publicado: (2014)

Distribution of Mycobacterium ulcerans in Buruli Ulcer Endemic and Non-Endemic Aquatic Sites in Ghana
por: Williamson, Heather R., et al.
Publicado: (2008)

Serologic response to culture filtrate antigens of Mycobacterium ulcerans during Buruli ulcer disease.
por: Dobos, K M, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_cbv3e0c4hjp7r5bd0nnid1uvka